DMDG 51st Open Meeting 2025.
September 1, 2025
We’re delighted to share that Martin Barrett, our Head of Business Development, and Rob Jenkins, our Bioanalytical Scientist, will be attending the 51st Open Meeting 2025.
This event is a fantastic opportunity to connect with industry leaders, share insights and build new collaborations.
Martin and Rob are looking forward to meeting fellow attendees, exchanging ideas and exploring ways to create impactful partnerships that advance drug discovery and development.
🤝 If you’re attending, don’t hesitate to reach out they’ll be happy to connect, discuss your projects, and explore potential synergies.
#Pharmidex #DrugDiscovery #DrugDevelopment #Collaboration #OpenMeeting2025
🌟 Exciting Announcement from Pharmidex ! 🌟 We’re delighted to share that our Head of Business Development, Martin Barrett , will be attending the upcoming conference: ELRIG Drug Discovery 2025 (21–22 October 2025 | Liverpool, UK). Martin will be eager to connect with fellow life-sciences innovators, exchange ideas and explore new collaborations and opportunities to accelerate drug discovery and development. If you’ll be at the event, we’d love to invite you to meet Martin for a chat about how we can work together. See you in Liverpool!
GMP 37th Symposium
Pharmidex will be attending the GMP 37th Symposium
